75 related articles for article (PubMed ID: 17499716)
1. Alternative cyclin D1 forms a and b have different biological functions in the cell cycle of B lymphocytes.
Lévêque C; Marsaud V; Renoir JM; Sola B
Exp Cell Res; 2007 Jul; 313(12):2719-29. PubMed ID: 17499716
[TBL] [Abstract][Full Text] [Related]
2. Cyclin D1b variant promotes cell invasiveness independent of binding to CDK4 in human bladder cancer cells.
Kim CJ; Nishi K; Isono T; Okuyama Y; Tambe Y; Okada Y; Inoue H
Mol Carcinog; 2009 Oct; 48(10):953-64. PubMed ID: 19415719
[TBL] [Abstract][Full Text] [Related]
3. Cytoplasmic sequestration of cyclin D1 associated with cell cycle withdrawal of neuroblastoma cells.
Sumrejkanchanakij P; Eto K; Ikeda MA
Biochem Biophys Res Commun; 2006 Feb; 340(1):302-8. PubMed ID: 16364255
[TBL] [Abstract][Full Text] [Related]
4. Expression of cyclin D1 splice variants is differentially associated with outcome in non-small cell lung cancer patients.
Li R; An SJ; Chen ZH; Zhang GC; Zhu JQ; Nie Q; Xie Z; Guo AL; Mok TS; Wu YL
Hum Pathol; 2008 Dec; 39(12):1792-801. PubMed ID: 18715616
[TBL] [Abstract][Full Text] [Related]
5. Ectopic cyclin D1 overexpression increases chemosensitivity but not cell proliferation in multiple myeloma.
Kuroda Y; Sakai A; Tsuyama N; Katayama Y; Munemasa S; Asaoku H; Okikawa Y; Nakaju N; Mizuno M; Ogawa K; Nishisaka T; Matsui H; Tanaka H; Kimura A
Int J Oncol; 2008 Dec; 33(6):1201-13. PubMed ID: 19020753
[TBL] [Abstract][Full Text] [Related]
6. Relevance of cyclin D1b expression and CCND1 polymorphism in the pathogenesis of multiple myeloma and mantle cell lymphoma.
Krieger S; Gauduchon J; Roussel M; Troussard X; Sola B
BMC Cancer; 2006 Oct; 6():238. PubMed ID: 17022831
[TBL] [Abstract][Full Text] [Related]
7. The relative levels of cyclin D1a and D1b alternative transcripts in mantle cell lymphoma may depend more on sample origin than on CCND1 polymorphism.
Carrère N; Belaud-Rotureau MA; Dubus P; Parrens M; de Mascarel A; Merlio JP
Haematologica; 2005 Jun; 90(6):854-6. PubMed ID: 15951302
[TBL] [Abstract][Full Text] [Related]
8. Cyclin D1/cdk4 can interact with E2F4/DP1 and disrupts its DNA-binding capacity.
Scimè A; Li L; Ciavarra G; Whyte P
J Cell Physiol; 2008 Mar; 214(3):568-81. PubMed ID: 17894419
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of hypoxia-induced apoptosis of human breast cancer cells via STAT5b by momilactone B.
Joung YH; Lim EJ; Kim MS; Lim SD; Yoon SY; Lim YC; Yoo YB; Ye SK; Park T; Chung IM; Bae KY; Yang YM
Int J Oncol; 2008 Sep; 33(3):477-84. PubMed ID: 18695876
[TBL] [Abstract][Full Text] [Related]
10. Cyclin D1 splice variants. Differential effects on localization, RB phosphorylation, and cellular transformation.
Solomon DA; Wang Y; Fox SR; Lambeck TC; Giesting S; Lan Z; Senderowicz AM; Conti CJ; Knudsen ES
J Biol Chem; 2003 Aug; 278(32):30339-47. PubMed ID: 12746453
[TBL] [Abstract][Full Text] [Related]
11. Involvement of cyclin D1/CDK4 and pRb mediated by PI3K/AKT pathway activation in Pb2+ -induced neuronal death in cultured hippocampal neurons.
Li C; Xing T; Tang M; Yong W; Yan D; Deng H; Wang H; Wang M; Chen J; Ruan D
Toxicol Appl Pharmacol; 2008 Jun; 229(3):351-61. PubMed ID: 18353414
[TBL] [Abstract][Full Text] [Related]
12. Requirement for CDK4 kinase function in breast cancer.
Yu Q; Sicinska E; Geng Y; Ahnström M; Zagozdzon A; Kong Y; Gardner H; Kiyokawa H; Harris LN; Stål O; Sicinski P
Cancer Cell; 2006 Jan; 9(1):23-32. PubMed ID: 16413469
[TBL] [Abstract][Full Text] [Related]
13. The RelA/p65 subunit of NF-kappaB specifically regulates cyclin D1 protein stability: implications for cell cycle withdrawal and skeletal myogenesis.
Dahlman JM; Wang J; Bakkar N; Guttridge DC
J Cell Biochem; 2009 Jan; 106(1):42-51. PubMed ID: 19016262
[TBL] [Abstract][Full Text] [Related]
14. An alternatively spliced cyclin D1 isoform, cyclin D1b, is a nuclear oncogene.
Lu F; Gladden AB; Diehl JA
Cancer Res; 2003 Nov; 63(21):7056-61. PubMed ID: 14612495
[TBL] [Abstract][Full Text] [Related]
15. Evidence that leptin through STAT and CREB signaling enhances cyclin D1 expression and promotes human endometrial cancer proliferation.
Catalano S; Giordano C; Rizza P; Gu G; Barone I; Bonofiglio D; Giordano F; Malivindi R; Gaccione D; Lanzino M; De Amicis F; Andò S
J Cell Physiol; 2009 Mar; 218(3):490-500. PubMed ID: 18988190
[TBL] [Abstract][Full Text] [Related]
16. The role and mechanism of progesterone receptor activation of extra-nuclear signaling pathways in regulating gene transcription and cell cycle progression.
Boonyaratanakornkit V; Bi Y; Rudd M; Edwards DP
Steroids; 2008 Oct; 73(9-10):922-8. PubMed ID: 18321550
[TBL] [Abstract][Full Text] [Related]
17. Cyclin D1 inhibits mitochondrial activity in B cells.
Tchakarska G; Roussel M; Troussard X; Sola B
Cancer Res; 2011 Mar; 71(5):1690-9. PubMed ID: 21343394
[TBL] [Abstract][Full Text] [Related]
18. Berberine inhibits cyclin D1 expression via suppressed binding of AP-1 transcription factors to CCND1 AP-1 motif.
Luo Y; Hao Y; Shi TP; Deng WW; Li N
Acta Pharmacol Sin; 2008 May; 29(5):628-33. PubMed ID: 18430372
[TBL] [Abstract][Full Text] [Related]
19. Cyclin D1 mediates resistance to apoptosis through upregulation of molecular chaperones and consequent redistribution of cell death regulators.
Roué G; Pichereau V; Lincet H; Colomer D; Sola B
Oncogene; 2008 Aug; 27(36):4909-20. PubMed ID: 18438428
[TBL] [Abstract][Full Text] [Related]
20. Thrombin stimulates RPE cell proliferation by promoting c-Fos-mediated cyclin D1 expression.
Parrales A; Palma-Nicolás JP; López E; López-Colomé AM
J Cell Physiol; 2010 Feb; 222(2):302-12. PubMed ID: 19847806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
